The most sensitive fusion transcript is MAN2A1-FER, reaching 82.3%, while several fusion transcripts such as TRMT11-GRIK2 were mostly not detectable in the blood even they were present in the prostate cancer samples. This evidence concerns the gene FER and prostate carcinoma.